Unifav 200 mg (Tablet)
Unit Price: ৳ 200.00 (3 x 10: ৳ 6,000.00)
Strip Price: ৳ 2,000.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Favipiravir |
| Company | Unimed unihealth pharmaceuticals ltd |
Indications
- Treatment of novel or re-emerging pandemic influenza virus infections (limited to cases in which other influenza antiviral drugs are ineffective or not sufficiently effective)
Description
- Approved for manufacture and sale in Japan as an influenza antiviral
- Selective inhibition of the RNA polymerase of the influenza virus
- Effective in treating COVID-19 during outbreaks of novel or re-emerging influenza virus infections
- Production and distribution at the discretion of Japan’s Health, Labor and Welfare Ministry
Pharmacology
- Metabolized into favipiravir ribosyl triphosphate (favipiravir RTP)
- Selectively inhibits RNA polymerase of the influenza virus
- Effective against all types and sub-types of human influenza A, B, and C viruses in vitro
Dosage & Administration
- Usual adult dosage: 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5
- Total treatment duration should be 5 days
Interaction
- In animal studies: decreased RBC production, increased liver function parameters such as AST, ALP, ALT, and total bilirubin
- Toxicity information regarding Unifav in humans is not readily available
Contraindications
- Contraindicated for pregnant women and women who may possibly be pregnant
Side Effects
- Most common side effects: diarrhea and increase of blood uric acid levels
Pregnancy & Lactation
- May cause delayed development or death of embryos during the early stage of pregnancy
- Should not be given during pregnancy
Precautions & Warnings
- Not to be given in pregnant women
- Confirmation of non-pregnancy in women of childbearing potential before use
- Thorough contraception measures from the start of the treatment to 7 days after the end of the treatment
- Caution should be taken for Hepatic and renal impaired patients or use Unifav as per the direction of registered Physician
Use in Special Populations
- Approved as an experimental drug, further studies needed about efficacy, toxic reactions, and use in children
Overdose Effects
- In animal studies: decreased RBC production, increased liver function parameters such as AST, ALP, ALT, and total bilirubin
- Toxicity information regarding Unifav in humans is not readily available
Therapeutic Class
- Anti-viral drugs
Storage Conditions
- Keep below 30°C temperature
- Protected from light & moisture
- Keep out of the reach of children